Advertisement

Topics

Marion Schlegel: Novartis, BB Biotech und Clovis in der Analyse

04:16 EDT 21 Jun 2017 | FinanzNachrichten

Marion Schlegel vom Anlegermagazin DER AKTIONÄR blickt in dieser Sendung auf die Pharma- und Biotechbranche. Heute geht es um Novartis, BB Biotech und Clovis. Die Aktie von Clovis hatte zu Wochenbe...

Original Article: Marion Schlegel: Novartis, BB Biotech und Clovis in der Analyse

NEXT ARTICLE

More From BioPortfolio on "Marion Schlegel: Novartis, BB Biotech und Clovis in der Analyse"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...